MAPK14 and non-small cell lung carcinoma: MAPK14 was previously reported to predict the risk, chemotherapy toxicity, and tumor progression in non-small cell lung cancer [30, 31, 62] and was identified as a critical target of various anti-tumor herbal compounds, such as Andrographis and Polygonatum cyrtonema Hua [63, 64].